We are live on ! Find out more
BME icon

BlackRock Health Sciences Trust

62 hedge funds and large institutions have $93M invested in BlackRock Health Sciences Trust in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

0.63% more ownership

Funds ownership: 18.43%19.05% (+0.63%)

0% more funds holding

Funds holding: 6262 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

5% less capital invested

Capital invested by funds: $98.2M → $93M (-$5.18M)

Holders
62
Holders Change
Holders Change %
0%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
29
Reduced
13
Closed
6
Calls
Puts
Net Calls
Net Calls Change

BME Hedge Fund Activity: Q3 2022 in Review

62 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust (BME) for Q3 2022, worth a combined $93M — down 5.3% from $98.2M a quarter earlier.

Fund positioning in BME was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 29 added to existing stakes and 13 trimmed.

The largest buyer was Atria Wealth Solutions, opening a new position worth an estimated $2.2M. The largest seller was Ameriprise, cutting an estimated $3.76M.

  • 62 institutional investors held BlackRock Health Sciences Trust (BME) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $93M of BlackRock Health Sciences Trust stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 6 funds opened new BlackRock Health Sciences Trust positions in Q3 2022 and 6 closed out, a net change of 0 holders.
  • The largest BlackRock Health Sciences Trust buyer in Q3 2022 was Atria Wealth Solutions, an estimated $2.2M added.
  • The largest BlackRock Health Sciences Trust seller in Q3 2022 was Ameriprise, an estimated $3.76M sold.

Based on aggregated 13F filings for Q3 2022.